Synopsis
0
USDMF
0
JDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Benzidamine
2. Benzindamine
3. Benzydamine
4. Benzydamine Monohydrochloride
5. Difflam
6. Hydrochloride, Benzydamine
7. Lonol
8. Monohydrochloride, Benzydamine
9. Novo Benzydamine
10. Novo-benzydamine
11. Opalgyne
12. Pms Benzydamine
13. Pms-benzydamine
14. Ratio Benzydamine
15. Ratio-benzydamine
16. Rosalgin
17. Sun Benz
18. Sun-benz
19. Tantum
20. Tantum Topico
1. 132-69-4
2. Benzydamine Hcl
3. Benzidamine Hydrochloride
4. Benzindamine Hydrochloride
5. Tantum
6. Benzydamine (hydrochloride)
7. Af-864
8. Nsc-759276
9. 132-69-4 (hcl)
10. K2gi407r4q
11. Benalgin
12. {3-[(1-benzyl-1h-indazol-3-yl)oxy]propyl}dimethylamine Hydrochloride
13. 1-benzyl-3-(3-(dimethylamino)propoxy)-1h-indazole Monohydrochloride
14. 3-((1-benzyl-1h-indazol-3-yl)oxy)-n,n-dimethylpropan-1-amine Hydrochloride
15. 1-propanamine, N,n-dimethyl-3-((1-(phenylmethyl)-1h-indazol-3-yl)oxy)-, Monohydrochloride
16. Benzidan
17. Benzyrin
18. Difflam
19. Dorinamin
20. Enzamin
21. Epirotin
22. Flogaton
23. Imotryl
24. Oxinazin
25. Ririlim
26. Riripen
27. Salyzoron
28. Tamas
29. Verax
30. 1-benzyl-3-(3-(dimethylamino)propoxy)-1h-indazole Hydrochloride
31. 1-benzyl-3-(3-[dimethylamino]propoxy)-1h-indazole Hydrochloride
32. Dsstox_cid_25293
33. Dsstox_rid_80786
34. Dsstox_gsid_45293
35. 1-benzyl-3-[3-(dimethylamino)propoxy]-1h-indazole Hydrochloride
36. 3-(1-benzylindazol-3-yl)oxy-n,n-dimethylpropan-1-amine;hydrochloride
37. Smr000544402
38. Ncgc00016397-01
39. Cas-132-69-4
40. Einecs 205-076-0
41. Af 864
42. Af864
43. Benzydamine Hydrochloride [usan:jan]
44. Unii-k2gi407r4q
45. Sr-01000799149
46. Benzydamine, Hcl
47. Prestwick_403
48. Tantum (tn)
49. 1-benzyl-3-gamma-dimethylaminopropoxy-1h-indazole Hydrochloride
50. 1-propanamine, N,n-dimethyl-3-((1-(phenylmethyl)-1h-indazol-3-yl)oxy)-, Hydrochloride
51. Schembl42644
52. Benzydaminehydrochloride
53. Mls001216204
54. Mls001306431
55. Mls001333107
56. Mls001333108
57. Mls002222210
58. Not Available;benzydamine Hcl
59. Benzydamine-[d6] Hydrochloride
60. Chembl1528134
61. Dtxsid1045293
62. Chebi:31266
63. Hms1568l16
64. Pharmakon1600-01505975
65. Bcp12133
66. Tox21_110420
67. Hy-30235a
68. Mfcd00078957
69. Nsc759276
70. S4165
71. Benzydamine Hydrochloride (jan/usan)
72. Benzydamine Hydrochloride [mi]
73. 1h-indazole, 1-benzyl-3-(3-(dimethylamino)propoxy)-, Monohydrochloride
74. 3-((1-benzyl-1h-indazol-3-yl)oxy)-n,n-dimethylpropylamine Monohydrochloride
75. Akos015994635
76. Tox21_110420_1
77. Ac-6791
78. Benzydamine Hydrochloride [jan]
79. Ccg-213582
80. Cs-4463
81. Hs-1002
82. Nsc 759276
83. Benzydamine Hydrochloride [usan]
84. Benzydamine Hydrochloride [mart.]
85. Ncgc00016397-04
86. Benzydamine Hydrochloride [who-dd]
87. 1-benzyl-3-hydroxy-1h-indazolesodiumsalt
88. B3751
89. Ft-0662621
90. Sw196646-3
91. Benzydamine Hydrochloride, Analytical Standard
92. A14562
93. Benzydamine Hydrochloride [ep Monograph]
94. D01410
95. H10439
96. A854848
97. J-006209
98. Sr-01000799149-4
99. Q27281858
100. 1-benzyl-3-(3-(dimethylamino) Propoxy)-1h Indozale Hydrochloride
101. 3-(1-benzyl-1h-indazol-3-yloxy)-n,n-dimethylpropan-1-amine Hydrochloride
| Molecular Weight | 345.9 g/mol |
|---|---|
| Molecular Formula | C19H24ClN3O |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 7 |
| Exact Mass | 345.1607901 g/mol |
| Monoisotopic Mass | 345.1607901 g/mol |
| Topological Polar Surface Area | 30.3 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 344 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Anti-Inflammatory Agents
Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
ABOUT THIS PAGE
61
PharmaCompass offers a list of Benzydamine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Benzydamine Hydrochloride manufacturer or Benzydamine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Benzydamine Hydrochloride manufacturer or Benzydamine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Benzydamine Hydrochloride API Price utilized in the formulation of products. Benzydamine Hydrochloride API Price is not always fixed or binding as the Benzydamine Hydrochloride Price is obtained through a variety of data sources. The Benzydamine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Indolin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Indolin, including repackagers and relabelers. The FDA regulates Indolin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Indolin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Indolin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Indolin supplier is an individual or a company that provides Indolin active pharmaceutical ingredient (API) or Indolin finished formulations upon request. The Indolin suppliers may include Indolin API manufacturers, exporters, distributors and traders.
click here to find a list of Indolin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Indolin Drug Master File in Korea (Indolin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Indolin. The MFDS reviews the Indolin KDMF as part of the drug registration process and uses the information provided in the Indolin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Indolin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Indolin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Indolin suppliers with KDMF on PharmaCompass.
A Indolin CEP of the European Pharmacopoeia monograph is often referred to as a Indolin Certificate of Suitability (COS). The purpose of a Indolin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Indolin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Indolin to their clients by showing that a Indolin CEP has been issued for it. The manufacturer submits a Indolin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Indolin CEP holder for the record. Additionally, the data presented in the Indolin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Indolin DMF.
A Indolin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Indolin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Indolin suppliers with CEP (COS) on PharmaCompass.
A Indolin written confirmation (Indolin WC) is an official document issued by a regulatory agency to a Indolin manufacturer, verifying that the manufacturing facility of a Indolin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Indolin APIs or Indolin finished pharmaceutical products to another nation, regulatory agencies frequently require a Indolin WC (written confirmation) as part of the regulatory process.
click here to find a list of Indolin suppliers with Written Confirmation (WC) on PharmaCompass.
Indolin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Indolin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Indolin GMP manufacturer or Indolin GMP API supplier for your needs.
A Indolin CoA (Certificate of Analysis) is a formal document that attests to Indolin's compliance with Indolin specifications and serves as a tool for batch-level quality control.
Indolin CoA mostly includes findings from lab analyses of a specific batch. For each Indolin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Indolin may be tested according to a variety of international standards, such as European Pharmacopoeia (Indolin EP), Indolin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Indolin USP).
